Alfonso Quintás-Cardama
Chief Tech/Sci/R&D Officer chez FOGHORN THERAPEUTICS INC.
Fortune : - $ au 31/03/2024
Profil
Alfonso Quintás-Cardama is currently the Chief Medical Officer at Foghorn Therapeutics, Inc. He previously worked as the Head of the Cell & Gene Therapies Unit at GSK Plc, Assistant Professor at The University of Texas M.D.
Anderson Cancer Center, and Chief Medical Officer at TCR2 Therapeutics, Inc. He holds a doctorate degree from the University of Santiago de Compostela.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 24/01/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Alfonso Quintás-Cardama
| Sociétés | Poste | Début |
|---|---|---|
| FOGHORN THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 11/09/2023 |
Anciens postes connus de Alfonso Quintás-Cardama
| Sociétés | Poste | Fin |
|---|---|---|
The University of Texas M.D. Anderson Cancer Center
 The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services The University of Texas M.D. Anderson Cancer Center provides cancer patient care, research, and prevention for cancer. The firm also provides education for undergraduate and graduate students, trainees, professionals, employees and the publics. The company was founded in 1941 and is headquartered in Houston, TX. | Corporate Officer/Principal | 01/01/2014 |
| GSK PLC | Corporate Officer/Principal | - |
| TCR2 THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | - |
Formation de Alfonso Quintás-Cardama
| University of Santiago de Compostela | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| GSK PLC | Health Technology |
| FOGHORN THERAPEUTICS INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
The University of Texas M.D. Anderson Cancer Center
The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services The University of Texas M.D. Anderson Cancer Center provides cancer patient care, research, and prevention for cancer. The firm also provides education for undergraduate and graduate students, trainees, professionals, employees and the publics. The company was founded in 1941 and is headquartered in Houston, TX. | Consumer Services |
TCR2 Therapeutics, Inc.
 TCR2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology TCR2 Therapeutics, Inc. is a clinical-stage cell therapy company, which engages in the development of biological drugs and engineering T-cells for cancer therapy. It is also involved in the research and collaboration with academic laboratories and industry partners in the field of T-cell immunology, cell therapy, gene editing, and process development. The company was founded by Patrick A. Baeuerle on May 29, 2015 and is headquartered in Cambridge, MA. | Health Technology |
